# Clear Secure, Inc.: financial statements, quarterly

YOU · NYSE · CIK 1856314 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/you.md) · [Financials](/companies/you/financials.md) · [Filings](/companies/you/filings.md) · [Insiders](/companies/you/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/you/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [160](/filings/0001856314-24-000134.md) | [171 d](/filings/0001856314-26-000006.md) | [179](/filings/0001856314-25-000054.md) | [187](/filings/0001856314-25-000143.md) | [198](/filings/0001856314-25-000149.md) | [206 d](/filings/0001856314-26-000006.md) | [211](/filings/0001628280-26-030937.md) | [219](/filings/0001856314-26-000042.md) | [229](/filings/0001856314-25-000149.md) | [241 d](/filings/0001856314-26-000006.md) | [253](/filings/0001628280-26-030937.md) | [278](/filings/0001856314-26-000042.md) |
| Research and development | $m | [11.8](/filings/0001856314-24-000134.md) | [18.4 d](/filings/0001856314-26-000006.md) | [20.1](/filings/0001856314-25-000054.md) | [17.4](/filings/0001856314-25-000143.md) | [17.4](/filings/0001856314-25-000149.md) | [18.4 d](/filings/0001856314-26-000006.md) | [19.0](/filings/0001628280-26-030937.md) | [18.2](/filings/0001856314-26-000042.md) | [18.0](/filings/0001856314-25-000149.md) | [17.2 d](/filings/0001856314-26-000006.md) | [19.5](/filings/0001628280-26-030937.md) | [17.8](/filings/0001856314-26-000042.md) |
| Operating income | $m | [19.3](/filings/0001856314-24-000134.md) | [15.7 d](/filings/0001856314-26-000006.md) | [23.7](/filings/0001856314-25-000054.md) | [30.3](/filings/0001856314-25-000143.md) | [35.1](/filings/0001856314-25-000149.md) | [34.1 d](/filings/0001856314-26-000006.md) | [37.4](/filings/0001628280-26-030937.md) | [42.6](/filings/0001856314-26-000042.md) | [52.6](/filings/0001856314-25-000149.md) | [53.9 d](/filings/0001856314-26-000006.md) | [62.0](/filings/0001628280-26-030937.md) | [83.0](/filings/0001856314-26-000042.md) |
| Income tax | $m | [0.8](/filings/0001856314-24-000134.md) | [(0.1) d](/filings/0001856314-26-000006.md) | [2.0](/filings/0001856314-25-000054.md) | [0.4](/filings/0001856314-25-000143.md) | [4.8](/filings/0001856314-25-000149.md) | [(166) d](/filings/0001856314-26-000006.md) | [5.4](/filings/0001628280-26-030937.md) | [6.4](/filings/0001856314-26-000042.md) | [15.7](/filings/0001856314-25-000149.md) | [10.3 d](/filings/0001856314-26-000006.md) | [14.4](/filings/0001628280-26-030937.md) | [19.0](/filings/0001856314-26-000042.md) |
| Net income | $m | [15.3](/filings/0001856314-24-000134.md) | [14.0 d](/filings/0001856314-26-000006.md) | [18.8](/filings/0001856314-25-000054.md) | [24.1](/filings/0001856314-25-000143.md) | [23.5](/filings/0001856314-25-000149.md) | [103 d](/filings/0001856314-26-000006.md) | [25.4](/filings/0001628280-26-030937.md) | [24.7](/filings/0001856314-26-000042.md) | [28.3](/filings/0001856314-25-000149.md) | [30.8 d](/filings/0001856314-26-000006.md) | [38.8](/filings/0001628280-26-030937.md) | [50.1](/filings/0001856314-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [63.5](/filings/0001856314-24-000134.md) | [57.9](/filings/0001856314-26-000006.md) | [64.1](/filings/0001856314-25-000054.md) | [39.1](/filings/0001856314-25-000143.md) | [32.9](/filings/0001856314-25-000149.md) | [66.9](/filings/0001856314-26-000006.md) | [87.6](/filings/0001628280-26-030937.md) | [89.3](/filings/0001856314-26-000042.md) | [75.8](/filings/0001856314-25-000149.md) | [85.7](/filings/0001856314-26-000042.md) | [171](/filings/0001628280-26-030937.md) | [128](/filings/0001856314-26-000042.md) |
| Current assets | $m | [781](/filings/0001856314-23-000034.md) | [770](/filings/0001856314-25-000008.md) | [744](/filings/0001856314-24-000060.md) | [714](/filings/0001856314-24-000108.md) | [596](/filings/0001856314-24-000134.md) | [662](/filings/0001856314-26-000006.md) | [582](/filings/0001856314-25-000054.md) | [654](/filings/0001856314-25-000143.md) | [589](/filings/0001856314-25-000149.md) | [765](/filings/0001856314-26-000042.md) | [865](/filings/0001628280-26-030937.md) | [1,024](/filings/0001856314-26-000042.md) |
| Total assets | $m | [1,062](/filings/0001856314-23-000034.md) | [1,045](/filings/0001856314-25-000008.md) | [1,017](/filings/0001856314-24-000060.md) | [982](/filings/0001856314-24-000108.md) | [859](/filings/0001856314-24-000134.md) | [1,195](/filings/0001856314-26-000006.md) | [1,111](/filings/0001856314-25-000054.md) | [1,180](/filings/0001856314-25-000143.md) | [1,126](/filings/0001856314-25-000149.md) | [1,303](/filings/0001856314-26-000042.md) | [1,422](/filings/0001628280-26-030937.md) | [1,578](/filings/0001856314-26-000042.md) |
| Current liabilities | $m | [478](/filings/0001856314-23-000034.md) | [552](/filings/0001856314-25-000008.md) | [625](/filings/0001856314-24-000060.md) | [633](/filings/0001856314-24-000108.md) | [558](/filings/0001856314-24-000134.md) | [643](/filings/0001856314-26-000006.md) | [688](/filings/0001856314-25-000054.md) | [750](/filings/0001856314-25-000143.md) | [633](/filings/0001856314-25-000149.md) | [760](/filings/0001856314-26-000042.md) | [860](/filings/0001628280-26-030937.md) | [984](/filings/0001856314-26-000042.md) |
| Total liabilities | $m | [604](/filings/0001856314-23-000034.md) | [676](/filings/0001856314-25-000008.md) | [748](/filings/0001856314-24-000060.md) | [754](/filings/0001856314-24-000108.md) | [678](/filings/0001856314-24-000134.md) | [957](/filings/0001856314-26-000006.md) | [985](/filings/0001856314-25-000054.md) | [1,053](/filings/0001856314-25-000143.md) | [960](/filings/0001856314-25-000149.md) | [1,099](/filings/0001856314-26-000042.md) | [1,209](/filings/0001628280-26-030937.md) | [1,335](/filings/0001856314-26-000042.md) |
| Shareholders' equity | $m | [276](/filings/0001856314-23-000034.md) | [233](/filings/0001856314-25-000008.md) | [166](/filings/0001856314-24-000060.md) | [154](/filings/0001856314-24-000108.md) | [129](/filings/0001856314-24-000134.md) | [198](/filings/0001856314-26-000006.md) | [117](/filings/0001856314-25-000054.md) | [121](/filings/0001856314-25-000143.md) | [149](/filings/0001856314-25-000149.md) | [178](/filings/0001856314-26-000042.md) | [185](/filings/0001628280-26-030937.md) | [206](/filings/0001856314-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.9) d](/filings/0001856314-24-000134.md) | [94.1 d](/filings/0001856314-26-000006.md) | [80.3](/filings/0001856314-25-000054.md) | [115 d](/filings/0001856314-25-000143.md) | [(35.9) d](/filings/0001856314-25-000149.md) | [137 d](/filings/0001856314-26-000006.md) | [98.3](/filings/0001628280-26-030937.md) | [123 d](/filings/0001856314-26-000042.md) | [(47.3) d](/filings/0001856314-25-000149.md) | [198 d](/filings/0001856314-26-000006.md) | [190](/filings/0001628280-26-030937.md) | [201 d](/filings/0001856314-26-000042.md) |
| Capital expenditure | $m | [4.0 d](/filings/0001856314-24-000134.md) | [3.7 d](/filings/0001856314-26-000006.md) | [2.8](/filings/0001856314-25-000054.md) | [4.4 d](/filings/0001856314-25-000143.md) | [2.0 d](/filings/0001856314-25-000149.md) | [2.8 d](/filings/0001856314-26-000006.md) | [7.1](/filings/0001628280-26-030937.md) | [5.1 d](/filings/0001856314-26-000042.md) | [6.2 d](/filings/0001856314-25-000149.md) | [11.0 d](/filings/0001856314-26-000006.md) | [4.9](/filings/0001628280-26-030937.md) | [12.2 d](/filings/0001856314-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.